Michael L. Chou
UCL Queen Square Institute Of Neurology
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Plasma periaxin is a biomarker of peripheral nerve demyelination.
Journal: Brain : a journal of neurology
Published: November 14, 2024
GAD antibodies in neurological disease: a critical evaluation of the utility and treatment implications of GAD antibodies in clinical practice.
Journal: Journal of neurology
Published: September 16, 2024
Seasonal variation and temporal relationship to the COVID-19 pandemic of NMDA receptor antibody results.
Journal: Journal of neurology
Published: June 15, 2023
Peripherin is a biomarker of axonal damage in peripheral nervous system disease.
Journal: Brain : a journal of neurology
Published: March 27, 2023
The endogenous calpain inhibitor calpastatin attenuates axon degeneration in murine Guillain-Barré syndrome.
Journal: Journal of the peripheral nervous system : JPNS
Published: September 27, 2022
Serum and cerebrospinal fluid biomarker profiles in acute SARS-CoV-2-associated neurological syndromes.
Journal: Brain communications
Published: January 28, 2021
Psychosis in systemic lupus erythematosus (SLE): 40-year experience of a specialist centre.
Journal: Rheumatology (Oxford, England)
Published: November 03, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026